Silymarin is an over the counter food supplement that is sold as a liver enhancement and liver protection preparation. It is a major constituent of the seeds of Silybum marianum which is composed of a mixture of seven major components and several minor compounds. The seven major components: taxifolin, silychristin, silydianin, silybin A, silybin B, iso-silybin A and iso-silybin B were isolated and purified from the crude mixture of silymarin using preparative high performance liquid chromatography to determine which were the most effective for liver protection. Free radical scavenging, hydroxyl radical antioxidant capacity, oxygen radical antioxidant capacity, trolox-equivalent antioxidant capacity and total antioxidant capacity antioxidant activities were determined for each of the individual purified components as well as the crude silymarin mixture. Taxifolin was the most effective component for scavenging free radicals in the DPPH assay with an EC 50 of 32 μM far more effective than all other components which showed EC 50 ranging from 115 to 855 μM. Taxifolin was also found to be the most effective antioxidant in the oxygen radical antioxidant capacity (ORAC) assay with a trolox equivalent of 2.43 and the second most effective in the hydroxyl radical antioxidant capacity (HORAC) assay with a gallic acid equivalent of 0.57. Other antioxidants assays did not show significant differences between samples.
References
[1]
Ercal, N.; Gurer-Orhan, H.; Aykin-Burns, N. Toxic metals and oxidative stress part I: Mechanisms involved in metal-induced oxidative damage. Curr. Top. Med. Chem. 2001, 1, 529–539.
[2]
Jackson, A.L.; Loeb, L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 2001, 477, 7–21.
[3]
Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2003, 82, 47–95.
[4]
Livingstone, D.R. Contaminant-stimulated reactive oxygen species production and oxidative damage in aquatic organisms. Mar. Pollut. Bull. 2001, 42, 656–666.
[5]
Sohal, R.S.; Mockett, R.J.; Orr, W.C. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radic. Biol. Med. 2002, 33, 575–586, doi:10.1016/S0891-5849(02)00886-9.
[6]
Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of aging. Nature 2000, 408, 239–247.
[7]
Poca, E.; Rabinovitch-Chable, H.; Cook-Moreau, J.; Pages, M.; Rigaud, M. Lipoxygenase from Zea mays L. purification and physicochemical characteristics. Biochim. Biophys. Acta 1990, 107, 1045–1050.
[8]
Negi, A.S.; Kumar, J.K.; Luqman, S.; Shanker, K.; Gupta, M.M.; Khanuja, S.P. Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads. Med. Res. Rev. 2008, 28, 746–772, doi:10.1002/med.20115.
[9]
Qato, D.; Alexander, C.; Conti, R.; Johnson, M.; Schumm, P.; Lindau, S. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008, 300, 2867–2878, doi:10.1001/jama.2008.892.
[10]
Anthony, K.; Subramanya, G.; Uprichard, S.; Hammouda, F.; Saleh, M.A. Antioxidant and anti-hepatitis c viral activities of commercial milk thistle food supplements. Antioxidants 2013, 2, 23–36.
[11]
Flora, K.; Hahn, M.; Rosen, H.; Benner, K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 1998, 93, 139–143.
[12]
Mayer, K.; Myers, P.; Lee, S. Silymarin treatment of viral hepatitis: A systematic review. J. Viral Hepat. 2005, 12, 559–567, doi:10.1111/j.1365-2893.2005.00636.x.
[13]
Wellington, K.; Jarvis, B. Silymarin: A review of its clinical properties in the management of hepatic disorders. BioDrugs 2001, 15, 465–489, doi:10.2165/00063030-200115070-00005.
[14]
Saller, R.; Meier, R.; Brignoli, R. The use of silymarin in the treatment of liver diseases. Drugs 2001, 61, 2035–2063, doi:10.2165/00003495-200161140-00003.
[15]
Roy, S.; Gagan, G.; Agarwal, R. Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner. Carcinogenesis 2012, 33, 629–636, doi:10.1093/carcin/bgr299.
[16]
Chilampalli, S.; Zhang, X.; Fahmy, H. Chemopreventive effects of Honokiol on UVB-induced skin. Anticancer Res. 2010, 30, 777–783.
[17]
Wagoner, J.; Negash, A.; Kane, O. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 2010, 51, 1912–1921.
[18]
Saller, R.; Brignoli, R.; Melzer, J.; Meier, R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch. Komplementarmed. 2008, 15, 9–20.
[19]
David, Y.; Lee, W.; Yanze, L. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (Milk Thistle). J. Nat. Prod. 2003, 66, 1171–1174.
[20]
Anthony, K.; Saleh, M.A. Chemical profiling and antioxidant activity of commercial milk thistle food supplements. J. Chem. Pharm. Res. 2012, 4, 4440–4450.
[21]
Brand-Williams, W.; Cuvelier, M.; Berset, C. Use of free radical method to evaluate antioxidant activity. LWT-Food Sci. Technol. 1995, 28, 25–30, doi:10.1016/S0023-6438(95)80008-5.
[22]
Borges, R.S.; Pereira, G.A.; Vale, J.K.; Fran？a, L.C.; Monteiro, M.C.; Alves, C.N.; da Silva, A.B. Design and Evaluation of 4-Aminophenol and Salicylate Derivatives as Free-Radical Scavenger. Chem. Biol. Drug Des. 2013, 81, 414–419, doi:10.1111/cbdd.12096.
[23]
Bak？r, T.; Beker, B.Y.; S？nmezo？lu, I.; Imer, F.; Apak, R. Antioxidant and prooxidant effects of α-tocopherol in a linoleic acid-copper(II)-ascorbate system. Eur. J. Lipid Sci. Technol. 2013, 115, 372–376.
[24]
Horváthová, K.; Novotny, L.; Tóthová, D.; Vachálková, A. Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma 2004, 51, 395–399.
[25]
Kimb, T.S.; Deckerc, E.A.; Leea, J. Antioxidant capacities of α-tocopherol, trolox, ascorbic acid, and ascorbyl palmitate in riboflavin photosensitized oil-in-water emulsions. Food Chem. 2012, 133, 68–75, doi:10.1016/j.foodchem.2011.12.069.
[26]
Ramasamy, K.; Agarwal, R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008, 269, 352–362.
[27]
Svobodová, A.; Zdarilová, A.; Malisková, J.; Mikulková, H.; Walterová, D.; Vostalová, J. Attenuation of UVA-induced H. damage to human keratinocytes by silymarin. J. Dermatol. Sci. 2007, 46, 21–30.
[28]
Banaee, M.; Sureda, A.; Mirvaghefi, A.R.; Rafei, G.R. Effects of long-term silymarin oral supplementation on the blood biochemical profile of rainbow trout (Oncorhynchus mykiss). Fish Physiol. Biochem. 2011, 37, 885–896.
